Edward J. Dulac III - 19 Aug 2021 Form 4 Insider Report for FATE THERAPEUTICS INC (FATE)

Signature
/s/ Cindy R. Tahl, as Attorney-in-Fact
Issuer symbol
FATE
Transactions as of
19 Aug 2021
Net transactions value
-$306,602
Form type
4
Filing time
20 Aug 2021, 16:01:31 UTC
Next filing
30 Sep 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FATE Common Stock Sale $170,262 -1,937 -3.3% $87.90* 56,076 19 Aug 2021 Direct F1, F2
transaction FATE Common Stock Sale $130,670 -1,474 -2.6% $88.65* 54,602 19 Aug 2021 Direct F1, F3
transaction FATE Common Stock Sale $5,670 -63 -0.12% $90.00* 54,539 19 Aug 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 10,000 shares of Common Stock underlying RSUs granted to the reporting person on August 17, 2020. This sale was made pursuant to an irrevocable election by the reporting person to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
F2 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.42 to $88.33 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.47 to $89.26 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.